Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes

Tae Hyeon Kim, Yerin Hwang, Selin Woo, Kyeongmin Lee, Yejun Son, Seoyoung Park, Hyunjee Kim, Ju-Young Shin, YongHyun Cho, Dahye Shin, Dosang Cho, Kyung-Jae Lee, Chang Hyun Kim, Sang Youl Rhee, Dong Keon Yon

Open source

DOI
10.1097/md.0000000000050241
Published
2026-08-21
Container
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000050241,
  title = {Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes},
  author = {Tae Hyeon Kim and Yerin Hwang and Selin Woo and Kyeongmin Lee and Yejun Son and Seoyoung Park and Hyunjee Kim and Ju-Young Shin and YongHyun Cho and Dahye Shin and Dosang Cho and Kyung-Jae Lee and Chang Hyun Kim and Sang Youl Rhee and Dong Keon Yon},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000050241},
  url = {https://doi.org/10.1097/md.0000000000050241}
}

RIS

TY  - JOUR
TI  - Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes
AU  - Tae Hyeon Kim
AU  - Yerin Hwang
AU  - Selin Woo
AU  - Kyeongmin Lee
AU  - Yejun Son
AU  - Seoyoung Park
AU  - Hyunjee Kim
AU  - Ju-Young Shin
AU  - YongHyun Cho
AU  - Dahye Shin
AU  - Dosang Cho
AU  - Kyung-Jae Lee
AU  - Chang Hyun Kim
AU  - Sang Youl Rhee
AU  - Dong Keon Yon
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000050241
UR  - https://doi.org/10.1097/md.0000000000050241
ER  - 

APA

Kim, T. H., Hwang, Y., Woo, S., Lee, K., Son, Y., Park, S., Kim, H., Shin, J., Cho, Y., Shin, D., Cho, D., Lee, K., Kim, C. H., Rhee, S. Y., & Yon, D. K. (2026). Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes. Medicine. https://doi.org/10.1097/md.0000000000050241

Source records